STACK DAVID M

CIK 00012047886 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001204788

Recent Transactions

50 trades

Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-14+32,700→ 186,481 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2023-06-14+245,400→ 245,400 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-07$37.87/sh−5,326→ 153,781 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-06$38.99/sh−5,058→ 159,107 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-08$59.10/sh−7,039→ 149,040 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-08$60.33/sh−5,006→ 144,034 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-08$61.96/sh−501→ 142,251 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-06-08+160,900→ 160,900 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-08+21,500→ 163,751 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-08$61.31/sh−1,282→ 142,752 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-06$61.37/sh−11,965→ 156,079 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-04-28−22,500→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-04-28$10.81/sh+22,500→ 168,044 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-31$10.81/sh+22,500→ 145,544 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-03-31−22,500→ 22,500 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-25$10.81/sh+13,670→ 123,044 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-01-25−13,670→ 45,000 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-01-11$10.81/sh+15,000→ 109,374 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-01-11−15,000→ 58,670 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-11-16$10.81/sh+15,000→ 94,085 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-11-16−15,000→ 73,670 total
Disposition to Issuer
CHIASMA, INC
Stock Option (Right to Buy)
2021-08-05−72,683→ 0 total
Disposition to Issuer
CHIASMA, INC
Stock Option (Right to Buy)
2021-08-05−13,000→ 0 total
Disposition to Issuer
CHIASMA, INC
Stock Option (Right to Buy)
2021-08-05−13,000→ 0 total
Disposition to Issuer
CHIASMA, INC
Stock Option (Right to Buy)
2021-08-05−10,000→ 0 total
Disposition to Issuer
CHIASMA, INC
Common Stock
2021-08-05−25,000→ 0 total
Disposition to Issuer
CHIASMA, INC
Stock Option (Right to Buy)
2021-08-05−13,000→ 0 total
Disposition to Issuer
CHIASMA, INC
Stock Option (Right to Buy)
2021-08-05−13,000→ 0 total
Disposition to Issuer
CHIASMA, INC
Stock Option (Right to Buy)
2021-08-05−91,954→ 0 total
Award
AMARIN CORP PLC\UK$AMRN
Restricted Stock Units
2021-06-14+36,000→ 36,000 total
Award
AMARIN CORP PLC\UK$AMRN
Stock Option (Right to Buy)
2021-06-14+45,953→ 45,953 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-06-09+133,400→ 133,400 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-06-09+17,800→ 78,956 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-06-04$61.04/sh−14,905→ 61,156 total
Purchase
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2021-06-04$4.54/sh+10,000→ 40,000 total
Purchase
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2021-06-03$4.62/sh+5,000→ 30,000 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-05-12$10.81/sh+21,250→ 97,311 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-05-12−21,250→ 88,670 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-05-12$60.76/sh−2,970→ 94,341 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-05-12$62.08/sh−14,669→ 79,672 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-05-12$62.41/sh−3,611→ 76,061 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-05-11$60.78/sh−13,318→ 83,993 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-05-11$10.81/sh+21,250→ 97,311 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-05-11$61.19/sh−7,932→ 76,061 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-05-11−21,250→ 109,920 total
Gift
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-03-24−1,080→ 97,273 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-02-03$10.81/sh+21,250→ 97,311 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-02-03$71.42/sh−14,350→ 76,061 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-02-03$70.78/sh−6,900→ 90,411 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-02-03−21,250→ 131,170 total

Companies

Recent Filings

Address

MOLECULAR INSIGHT PHARMACEUTICALS, INC. 160 SECOND STREET

CAMBRIDGE, MA, 02142

View on SEC.gov